Consoldiated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	May. 31, 2015	May. 31, 2014	May. 31, 2015	May. 31, 2014
Income Statement [Abstract]
Revenues (includes related party revenue of $65,000 for the six and three-month periods ended May 31, 2015)	$ 65,927	$ 237,353	$ 66,821	$ 451,015
Costs and expenses:
Cost of services	11,599	113,455	12,225	237,489
Selling, general and administrative	100,648	319,782	167,966	679,338
Total costs and expenses	112,247	433,237	180,191	916,827
Loss from operations	(46,320)	(195,884)	(113,370)	(465,812)
Other income (expense):
Interest expense	$ (234,550)	(299,701)	(589,317)	(818,552)
Amortization of deferred finance costs		$ (24,866)	(5,305)	(42,725)
Gain on troubled debt restructuring	$ 1,538,145		2,065,614
Gain on sale of subsidiary				640,180
Gain on settlement of derivative liabilities	$ 1,107,495		1,223,448	300,686
Gain (loss) on change in derivative liabilities	(847,720)	$ (239,755)	(3,017,461)	14,072
Total other income (expense)	1,563,370	(564,322)	(323,021)	93,661
Net income (loss)	1,517,050	$ (760,206)	(436,391)	$ (372,151)
Income from noncontrolling interest	3,965		3,965
Net income (loss) attributable to Pervasip Corp.	1,513,085	$ (760,206)	(440,356)	$ (372,151)
Accretion of preferred stock dividends - beneficial conversion feature	51,429		87,970
Net income (loss) attributable to common stockholders	$ 1,461,656	$ (760,206)	$ (528,326)	$ (372,151)
Basic earnings (loss) per share	$ 0.00	$ (0.00)	$ (0.00)	$ (0.00)
Diluted earnings (loss) per share	$ 0.00	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding: Basic	3,231,962,508	1,007,499,997	2,448,541,449	946,116,664
Weighted average number of common shares outstanding: Diluted	25,626,238,785	1,007,499,997	2,448,541,449	946,116,664